Finally, the new data presented herein further reinforces the PTENP1-PTEN paradigm and highlights the utility of CRISPR technologies for investigations of pseudogene-parental gene transcript relationships in cancer and other diseases. This evidence concerns the gene PTENP1 and cancer.